xanthenes has been researched along with EHS Tumor in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horsman, MR; Murata, R; Overgaard, J; Siemann, DW | 1 |
| Lepler, S; Mercer, E; Rojiani, AM; Siemann, DW | 1 |
| Carter, SP; Darzynkiewicz, Z; Kapuscinski, J; Melamed, MR; Schmid, FA | 1 |
| Arbeit, JM; Hubesch, A; Karczmar, GS; Toy, BJ; Weiner, MW | 1 |
| Leeper, DB; Park, CH; Rowley, R; Thakur, ML | 1 |
| Horio, T; Kannan, Y; Matuo, Y; Nishikawa, K | 1 |
| Horio, T; Hosoi, K; Nakamura, T; Nishikawa, K | 1 |
7 other study(ies) available for xanthenes and EHS Tumor
| Article | Year |
|---|---|
Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Sarcoma, Experimental; Xanthenes; Xanthones | 2001 |
Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Vessels; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Mice; Mice, Inbred C3H; Mice, Nude; Necrosis; Neovascularization, Pathologic; Sarcoma, Experimental; Stilbenes; Tumor Cells, Cultured; Xanthenes; Xanthones | 2002 |
Cytostatic and cytotoxic properties of pyronin Y: relation to mitochondrial localization of the dye and its interaction with RNA.
Topics: Animals; Cell Compartmentation; Cell Cycle; Cell Line; Cell Survival; Cricetinae; DNA; Dose-Response Relationship, Drug; Intercalating Agents; Leukemia L1210; Mice; Mitochondria; Pyronine; RNA; Sarcoma, Experimental; Solubility; Xanthenes | 1986 |
Inhibition of tumor high-energy phosphate metabolism by insulin combined with rhodamine 123.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Brain; Dimethyl Sulfoxide; Energy Metabolism; Insulin; Magnetic Resonance Spectroscopy; Male; Phosphocreatine; Rats; Rats, Inbred F344; Rhodamine 123; Rhodamines; Sarcoma, Experimental; Xanthenes | 1988 |
Radioiodinated rhodamine-123: preparation and preliminary evaluation as an agent for tumor scintigraphy.
Topics: Adenocarcinoma; Animals; Cricetinae; Female; Iodine Radioisotopes; Isotope Labeling; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mitochondria; Neoplasm Transplantation; Neoplasms, Experimental; Ovarian Neoplasms; Radionuclide Imaging; Rhodamine 123; Rhodamines; Sarcoma, Experimental; Tissue Distribution; Xanthenes | 1988 |
Intracellular distribution of in vivo liver catalase-depressing substance in rhodamine sarcoma.
Topics: Animals; Carcinogens; Catalase; Cell Nucleolus; Cell Nucleus; Chromatin; Depression, Chemical; DNA, Neoplasm; Endotoxins; Liver; Mice; Microsomes, Liver; Mitochondria, Liver; Muscles; Neoplasm Proteins; Quaternary Ammonium Compounds; Rats; RNA, Neoplasm; Sarcoma, Experimental; Xanthenes | 1972 |
Effect of injection of chromatins from rhodamine sarcoma into rats on pI-isozymes of liver pyruvate kinase.
Topics: Animals; Carcinogens; Chromatin; DNA, Neoplasm; Erythrocytes; Isoelectric Focusing; Isoenzymes; Kidney; Kinetics; Liver; Lung; Male; Muscles; Myocardium; Neoplasm Proteins; Neoplasm Transplantation; Pyruvate Kinase; Quaternary Ammonium Compounds; Rats; RNA, Neoplasm; Sarcoma, Experimental; Spleen; Stimulation, Chemical; Xanthenes | 1972 |